Clarify the Role of the First Rx Melatonin for Insomnia
July 2026
Slenyto (melatonin extended-release 1 mg and 5 mg tabs) will be the first prescription melatonin product in Canada.
But it won’t be for everyone. It’s for kids 2 to 17 years old who have autism or Smith-Magenis syndrome (SMS)...a genetic disorder resulting in developmental, behavioural, and physical issues.
At least 80% of kids with these types of neurodevelopmental disabilities have sleep problems.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive